CAS 2160546-07-4

IACS-13909

CAS: 2160546-07-4

IACS-13909

Purity: ≥98%

Molecular weight: 377.27g/mol

Ref: 54-BUP03097

IACS-13909

CAS: 2160546-07-4

IACS-13909 (BBP-398), a specific and potent allosteric inhibitor of SHP2, that suppresses signaling through the MAPK pathway.

Formula: C₁₇H₁₈Cl₂N₆

Purity: 98.8%

Color and Shape: Solid

Molecular weight: 377.27

Ref: TM-T9196

IACS-13909

CAS: 2160546-07-4

IACS-13909 is a drug that binds to EGFR and inhibits the kinase activity of EGFR. It is being developed as an anti-cancer drug for the treatment of cancer, with a particular focus on cancers that are resistant to ibrutinib. IACS-13909 has shown potent anticancer activity in preclinical studies, with no adverse effects on healthy cells. IACS-13909 has been used in clinical trials for the treatment of cancer, with promising results.

Formula: C₁₇H₁₈Cl₂N₆

Purity: Min. 95%

Molecular weight: 377.3 g/mol

Ref: 3D-KLD54607